Clinical Trial Update: An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome [Phase 3]

View source ↗

Summary

An open-label extension Phase 3 trial assessing the long-term safety of ZX008 (fenfluramine hydrochloride) oral solution in children and young adults with Drave…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• ZX008 (fenfluramine hydrochloride)

Snippet

Sponsor: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | Conditions: Dravet Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2023-09-25